Antag Therapeutics is a biopharmaceutical company developing treatments for obesity and cardiometabolic diseases, focusing on injectable therapies like their novel GIPR antagonist, AT-7687.

Caresyntax develops AI-enabled surgical software that enhances surgical outcomes by integrating and analyzing comprehensive data to support real-time and post-surgical decision-making.

Caresyntax develops AI-enabled surgical software that enhances surgical outcomes by integrating and analyzing comprehensive data to support real-time and post-surgical decision-making.

RefleXion Medical develops and commercializes SCINTIX therapy, a novel treatment for all stages of indicated solid tumor cancers, including metastatic disease, delivered via the RefleXion X1 platform.

Mamaearth is a digital-first skincare and personal care brand that has raised $92 million in an anchor round ahead of its IPO, aiming to secure a total of $204.3 million, and plans to use the funds to support its growth and expansion.

Harbinger Health is a biotechnology company that is developing a blood-based cancer screening product, utilizing machine learning and proprietary insights into cancer biology, with the aim to make cancer screening globally accessible, affordable, and reduce false positives.

Generate:Biomedicines is a clinical-stage biotherapeutics company that uses a machine-learning-powered generative biology platform to develop new drugs across oncology, immunology, and infectious disease.